Less than half of people with latent TB in the US initiate therapy

Researchers uncovered gaps in the care cascade for latent tuberculosis in the United States, including that less than half of people diagnosed with latent TB in 2016 and 2017 initiated treatment.
“Tuberculosis remains a leading cause of death and morbidity from an infectious disease globally,” Maunank R. Shah, MD, PhD, associate professor of medicine in the division of infectious diseases at Johns Hopkins University School of Medicine, told Healio.
“In the U.S., TB elimination will require preventing progression to TB disease through the diagnosis and treatment of latent TB

Researchers uncovered gaps in the care cascade for latent tuberculosis in the United States, including that less than half of people diagnosed with latent TB in 2016 and 2017 initiated treatment.
“Tuberculosis remains a leading cause of death and morbidity from an infectious disease globally,” Maunank R. Shah, MD, PhD, associate professor of medicine in the division of infectious diseases at Johns Hopkins University School of Medicine, told Healio.
“In the U.S., TB elimination will require preventing progression to TB disease through the diagnosis and treatment of latent TB